Press release
Tamoxifen Market size and Key Trends in terms of volume and value 2015 - 2025
Tamoxifen is an antagonist of the estrogen receptor in breast tissue. It is a selective estrogen-receptor modulator used in the treatment of breast cancer. Tomoxifen act as antagonist in mammary tissue but it act as agonist in other tissues like endometrium. Tamoxifen is indicated for the treatment of metastatic breast cancer in women and men. It is also used in ductal carcinoma treatment.
Tamoxifen also used in the other treatments like McCune-Albright syndrome, Infertility, Gynecomastia, Angiogenesis, Gene Expression, Riedel’s Thyroiditis.
Tamoxifen belongs to selective estrogen receptor modulators (SERMs) class of drugs, which is having both estrogenic and anti-estrogenic effects. Tamoxifen has the same nucleus as diethylstilbestrol but possesses an additional side chain (Trans-isomer) which accounts for its anti-estrogenic activity.
Tamoxifen is a non-steroidal agent that binds to estrogen receptors (ER), causes a conformational change in the receptor. This results in a blockage or change in the expression of estrogen dependent genes. The prolonged binding of Tamoxifen to the nuclear chromatin of these results in reduced DNA polymerase activity, impaired thymidine utilization, blockade of estradiol uptake, and decreased estrogen response.
Tamoxifen is available in the form of tablet, Capsule and oral solution. Tablets are available in 10mg and 20mg sizes.
Tamoxifen Market: Drivers and Restraints
In the world Breast cancer is the most common cancer. Breast cancer is the second most common after the lung cancer. For the treatment of this cancer Tamoxifen is one of the choice. Increasing the cancer prevalence rate in developed countries and encouragement of government organizations like WHO (World Health Organization), American Cancer Institute in the prevention are driven the Tamoxifen Market. Governments of different countries also spreading awareness about breast cancer in the people.
Request free sample Report: http://www.futuremarketinsights.com/reports/sample/rep-gb-1084
However, the use of Tamoxifen is contra indicated in Pregnancy women. It has adverse effects like change in vaginal discharge, Anxiety, confusion, painful or difficult urination.
Tamoxifen Market: Segmentation
Global Tamoxifen is further segmented into following types
Based on Product
Tablet
Powder
Capsule
Oral solution
Based on Application
Breast Cancer
Other Application (McCune-Albright syndrome, Infertility, Gynecomastia, Angiogenesis, Gene Expression, Riedel’s Thyroiditis)
Based on Region
North America
Latin America
Western Europe
Eastern Europe
Asia Pacific EXCL. Japan
Middle East and Africa
Japan
Tamoxifen Market: Overview
Rapid increase in prevalence rate and government organizations role in prevention of rate and awareness about the cancer in people are increases the market and is expected to have a double digit growth in the forecast period (2015-2025).
Tamoxifen Market: Region- wise Outlook
Depending on geographic regions, the global Tamoxifen Market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific excluding Japan, Japan and Middle East & Africa.
The use of Tamoxifen Market is high in North America because it is having high prevalence rate in cancer, having good healthcare setup and people are having good awareness about health care. In Asia pacific region china and India also having rapid growth health care set up and the use of Tamoxifen. Europe also having good growth in this market.
Browse full report: http://www.futuremarketinsights.com/reports/tamoxifen-market
Tamoxifen Market: Key Players
Some of the key players in Global Tamoxifen are
AstraZeneca
Teva pharmaceuticals
Watson laboratories inc
Aegis pharmaceuticals inc
Mylan pharmaceuticals inc
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature.
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Tamoxifen Market size and Key Trends in terms of volume and value 2015 - 2025 here
News-ID: 333134 • Views: …
More Releases from FMI Ltd
IT Software and Services Market: Russian Industry Analysis and Opportunity Asses …
The market is expected to register a strong growth of 7.2% in its CAGR during the projected period to reach US$ 8,628.2 million by 2020. Both the IT software and services segments made considerable contribution to the overall growth of Russian IT market in the European region. Increased e-government and e-banking initiatives by governments and banks are some of the prominent factors driving the demand for IT software and services…
Global IoE (Internet of Everything) Market to Witness a 16.4% CAGR from 2014 to …
“Proliferation of connected devices, increased technology budgets by leading countries such as Finland and Singapore, and rising uptake of ICT goods, particularly in the Asia-Pacific region, will accelerate the growth of the global IoE market. Further, explosion of big data and a growing need for enhanced customer experience in public, telecom and media, and banking, financial services and insurance (BFSI) sectors are likely to increase the adoption of IoE solutions…
Smart Fitness Market Report Now Available at Top Global Research Firm
The market is expected to register a strong growth of 24.6% in its CAGR during the projected period to reach US$ 9,525.6 million by 2020. Thesmart fitnesscomponentsuch as smart accessories, strength training equipment and cardiovascular equipment made considerable contribution to the overall growth of smart fitness devices market across regions. Increased consumer spending on smart accessories and growing health concerns are some of the prominent factors driving the demand for…
IT Software and Service Market: Poland Industry Analysis and Opportunity Assessm …
The Poland IT software and service market is driven by factors such as changing consumer buying pattern, advanced technology adoption, and product innovation through mergers and acquisition. Further, presence of cloud computing, digital transformation and, enterprise mobility are expected to accelerate the Poland IT software & services market growth in the near future.
The Poland IT software and service market mainly represents two segments that includes software and services. In 2013,…
More Releases for Tamoxifen
Tamoxifen Market Is Booming Worldwide with Sanofi, Pfizer, Bayer
HTF MI introduces new research on Tamoxifen covering the micro level of analysis by competitors and key business segments (2023-2029). The Tamoxifen explores a comprehensive study of various segments like opportunities, size, development, innovation, sales, and overall growth of major players. The research is carried out on primary and secondary statistics sources and it consists of both qualitative and quantitative detailing. Some of the major key players profiled in the…
Tamoxifen Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Tamoxifen Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 102 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.
Click to view the full report TOC, figure and tables:
https://www.globalinforesearch.com/global-tamoxifen-market_p199874.html
Scope of the Report:
The worldwide market for Tamoxifen is…
Tamoxifen Market - Size, Share, Outlook, and Opportunity Analysis 2018-2026
Tamoxifen is a type of selective estrogen receptor modulator (SERM) indicated for the treatment of women with high risk of breast cancer. Since its approval in 1998, tamoxifen has been used to treat millions of patients diagnosed with hormone receptor positive, early stage of breast cancer after surgery to reduce the risk of recurrence. It is the first choice for treatment of premenopausal women. Tamoxifen is the generic name for…
Tamoxifen Market - Size, and Opportunity Analysis 2018-2026
Tamoxifen is a type of selective estrogen receptor modulator (SERM) indicated for the treatment of women with high risk of breast cancer. Since its approval in 1998, tamoxifen has been used to treat millions of patients diagnosed with hormone receptor positive, early stage of breast cancer after surgery to reduce the risk of recurrence. It is the first choice for treatment of premenopausal women. Tamoxifen is the generic name for…
Tamoxifen Market Drivers, Restraints, Opportunities, and Threats 2015 - 2025
Tamoxifen is an antagonist of the estrogen receptor in breast tissue. It is a selective estrogen-receptor modulator used in the treatment of breast cancer. Tomoxifen act as antagonist in mammary tissue but it act as agonist in other tissues like endometrium. Tamoxifen is indicated for the treatment of metastatic breast cancer in women and men. It is also used in ductal carcinoma treatment.
Tamoxifen also used in the other treatments like…
Tamoxifen Market Size, Analysis, and Forecast Report 2015-2025
Tamoxifen is an antagonist of the estrogen receptor in breast tissue. It is a selective estrogen-receptor modulator used in the treatment of breast cancer. Tomoxifen act as antagonist in mammary tissue but it act as agonist in other tissues like endometrium. Tamoxifen is indicated for the treatment of metastatic breast cancer in women and men. It is also used in ductal carcinoma treatment.
Tamoxifen also used in the other treatments like…
